Ultrasound EA (Ergonomic Advantage) table version; V2 (Vascular 2 Section) Echocardiography -An Ultrasound examination table
Published January 24, 2024 · Recall initiated: December 5, 2023
Summary
FDA records medical device Class II recall Z-0730-2024, published January 24, 2024 and initiated December 5, 2023. Recalling firm: Oakworks Inc; Status: Ongoing; Reported quantity: 28 units; Lot: (UDI): 00817463025521 S/N: VCF805597 VCF814488 VCF814750 VCF817222 VCF817223 VCF817720 VCF817721 VCF823450 VCF825629 VCF825630 VCF833350 VCF813968 VCF817520 VCF826533 VCF822117 VCF824501 VCF824502 VCF824503 VCF824504 VCF815120 VCF814849 VCF835728. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Backrest platform stress fracture - the table is not operational in an inclined position
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Oakworks Inc
- Distributor
- US Nationwide Distribution
- Lot
- (UDI): 00817463025521 S/N: VCF805597 VCF814488 VCF814750 VCF817222 VCF817223 VCF817720 VCF817721 VCF823450 VCF825629 VCF825630 VCF833350 VCF813968 VCF817520 VCF826533 VCF822117 VCF824501 VCF824502 VCF824503 VCF824504 VCF815120 VCF814849 VCF835728
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAUltrasound EA (Ergonomic Advantage) table versions; G3 Multi-Specialty Echocardiography and Multi-SpecialtyJanuary 24, 2024
- FDAUltrasound EA (Ergonomic Advantage) table versions; G3 (General 3 Section) Echocardiography -An UltrasoundJanuary 24, 2024
- FDAUltrasound EA (Ergonomic Advantage) table versions; G2 (GENERAL 2) -An Ultrasound examination tableJanuary 24, 2024
- FDA(1) Patient Information Center iX, Model No. 866389 (2) Patient Information Center iX Expand, Model No. 866390January 24, 2024
- FDA(1) CareEvent, Model No. 866435 (2) CareEvent Upgrade, Model no. 866436January 24, 2024
- FDAVACUETTE TUBE 4 ml FX Sodium Fluoride/Potassium Oxalate, Item #454297, 13x75 grey cap-black ring, non-ridged.January 24, 2024
Questions about this recall
Was Ultrasound EA (Ergonomic Advantage) table version; V2 (Vascular 2 Section) Echocardiography -An Ultrasound examination table recalled?
Yes. FDA published recall Z-0730-2024 on January 24, 2024. Reported hazard: Backrest platform stress fracture - the table is not operational in an inclined position
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit